Peters, Jay I MDSchool of Medicine |
|
| 4/2009 - Present | Chief, Division of Pulmonary and Critical Care Medicine | University of Texas Health Science Center at San Antonio, Medicine, San Antonio, TX |
| 1/2009 - Present | Adjunct Professor Pharmaceutics | University of Texas at Austin, Pharmacology, Austin, TX |
| 9/1996 - Present | Chair, Cold Blue Committee | South Texas Veterans Health Care System, Medicine, San Antonio, TX |
| 9/1996 - Present | Chair, Critical Care Committee | South Texas Veterans Health Care System, Medicine, San Antonio, TX |
| 9/1996 - Present | ACLS Instructor | South Texas Veterans Healthcare System, San Antonio, TX |
| 9/1996 - Present | Professor | The University of Texas Health Science Center at San Antonio, Medicine, San Antonio, TX |
| 9/1994 - Present | Medical Director | University of Texas Health Science Center at San Antonio, Department of Respiratory Therapy, San Antonio, TX |
| 8/1994 - Present | Medical Director | School of Allied Health, San Antonio, TX |
| 6/1984 - Present | Staff Physician and Staff Physician | The South Texas Veterans Healthcare System, Audie L Murphy Division, Pulmonary Diseases and Critical Care, San Antonio, TX |
| 6/1984 - Present | Assistant Foundation Scientist | Southwest Foundation for Biomedical Research, San Antonio, TX |
| Year | Degree | Discipline | Institution |
| 1983 | Postdoctoral Fellowship | Pulmonary/Critical Care/Infectious Disease (Pulmonary/Critical Care/Infectious Disease Fellowship) | Baylor College of Medicine Houston , TX |
| 1980 | Postdoctoral Fellowship | Internship and Residency (Infectious Diseases) | Baylor College of Medicine Houston , TX |
| 1980 | Residency | Chief Medical Resident (Chief Medical Resident, 7/80 - 12/80) | Baylor College of Medicine Houston , TX |
| 1976 | MD | Medicine (Alpha Omega Alpha) | Baylor College of Medicine Houston , TX |
| 1973 | BA | (Magna Cum Laude) | University of Texas at Austin Austin , TX |
| 1970 | BA | (Honors & Scholars Program) | Tulane University New Orleans , LA |
| Date | Description | Institution | # Students |
| 11/2013 - Present | Grand Rounds - Asthma 2013:Pathogenesis, Therapies and Controversies | North Shore LIJ | 100 students |
| 1/2012 - Present | Pre-Doctoral Student Supervision | University of Texas at Austin | |
| 1/2012 - Present | Pre-Doctoral Student Supervision | University of Texas at Austin | |
| 9/2008 - Present | Dilemma`s in the ICU | University of Texas Health Science Center at San Antonio | 50 students |
| Medical School Ethics Presentation | |||
| 7/2006 - Present | On Becoming a Doctor ? Foundations | The University of Texas Health Science Center | |
| 7/2006 - Present | Adv Clin Eval Skills | The University of Texas Health Science Center | |
| 6/2006 - Present | Internal Medicine Morning Report | University of Texas Health Science Center at San Antonio | 50 students |
| Faculty discussion for daily intern and resident morning conference. | |||
| 1/2006 - Present | Pre-Doctoral Student Supervision | University of Texas at Austin College of Pharmacy/UTHSCSA | |
| 7/2000 - Present | Intro to Clin Medicine | The University of Texas Health Science Center | |
| Annual Pulmonary ACES Course: Pre-clinical teaching using patients with a variety of pulmonary diseases (i.e., very severe chronic obstructive pulmonary disease, pulmonary fibrosis, and/or post-lung transplant) to emphasize physical exam techniques that emphasize the identification and diagnosis of pulmonary problems. | |||
| 9/1996 - Present | Post-Doctoral Student Supervision | University of Texas Health Science Center at San Antonio | |
| 9/1994 - Present | Post-Doctoral Student Supervision | University of Texas Health Science Center at San Antonio | |
| 9/1993 - Present | Post-Doctoral Student Supervision | University of Texas Health Science Center at San Antonio | |
| 9/1992 - Present | Post-Doctoral Student Supervision | University of Texas Health Science Center at San Antonio | |
| 9/1988 - Present | Post-Doctoral Student Supervision | University of Texas Health Science Center at San Antonio | |
| 9/1988 - Present | Post-Doctoral Student Supervision | University of Texas Health Science Center at San Antonio | |
| 9/1985 - Present | Post-Doctoral Student Supervision | University of Texas Health Science Center at San Antonio | |
| 9/1984 - Present | Post-Doctoral Student Supervision | University of Texas Health Science Center at San Antonio | |
| 7/1984 - Present | Post-Doctoral Student Supervision | The University of Texas Health Science Center at San Antonio and South TX Veterans Healthcare System | |
| 7/1984 - Present | Off Campus | The University of Texas Health Science Center | 10 students |
| Medicine Thoracic Clinic Attending, University Hospital-Downtown: 1/2 day clinic per week, 6-8 weeks, 5-6 contact hours/week. | |||
| 7/1984 - Present | Clinical Medicine II | The University of Texas Health Science Center | 10 students |
| South Texas Veterans Healthcare System, Pulmonary Clinic Attending: 1/2 day clinic per week for 16 weeks, 5-6 contact hours per week. | |||
| 7/1984 - Present | Clinical Medicine | The University of Texas Health Science Center | 20 students |
Abstract |
| Peters JI. Pleuran Fluid pH: Comparing analytical methods and the Impact on clinical decision making; 2017 May. |
| Estrada RA, Maselli DJ, Peters JI. Severe Dyspnea: A bone of Contention. American Thoracic Society Annual Meeting Washington, DC: American Thoracic Society; 2017 May. (ATS Annual Meeting). |
| Restrepo MI. Intratracheal Administration of Mesenchymal Stem Cells Improves survival in a mouse model of severe pneumococcal pneumonia; 2017 May. |
| Peters JI. Callithrix jacchus: a non-human primate model of mycobacterium avium complex pulmonary infection?; 2017 May. |
| Nambiar AM, Anzueto AR, Peters JI. Effectiveness and safety of mycophenolate mofetil in idiopathic pulmonary fibrosis; 2017 Apr. (PloS ONE; vol. 12, no. 4). |
| N.A. Hanania, S. S Braman, J. Ohar, Adams SG, A. Ari, S. Sanjar, J. Brooks, Peters JI, D.A. Mahler, Adewuya. Exploring Health Care Providers` Practice Gaps in Prescribing Inhalation Delivery Devices for the Management of COPD. Resultos from the Delivery Makes a Difference (DMaD) Survey: SUNOVION; 2017 Jan. (CHEST). |
| Amalakuhan Bravein, King Phoebe C, Peters JI, Malave AJ. "Itching from the Skin to the Lungs: case of Varicella pneumonia ?; 2015 Oct. (Chest). |
| Sha Liu, Allan B. Watts, Ju Du, Amanda Bui, Soraya Hengsawas, Peters JI, Robert O. Williams III. Formulation of a novel fixed dose combination of salmeterol xinafoate and mometasone furoate for inhaled drug delivery; 2015 Jul. (Eur J Pharm Biopharm). |
| Peters JI. Not your straighforward septic patient; 2015 Jan. (Am j Respir Crit Care Med). |
| Peters JI. Improved Inhaled Combination therapies through particle engineerin; 2015 Jan. |
| Mangat M, Amalakuhan B, Habib S, Reyes L, Anzueto AR, Levine SM, Peters JI, Restrepo MI. High Endocan Levels Predict the Need for Ventilatory Support Among Patients With Severe Sepsis; 2015 Jan. |
| Peters JI. ElevatedVascular Endothelial Injury markers are associated with the development of multiorgan failure and mortality in patients with severe sepsis and septic shock; 2015 Jan. (CHEST). |
| Peters JI. Activation of the Inflammasome is not associated iwth multiorgan failure in bacteremic Patients with severe sepsis; 2015 Jan. (CHEST). |
| Yi-Bo Wang, Alan B. Watts, Peters JI, Robert O. Williams III. The Impact of Pulmonary Diseases on the Fate of Inhaled Medicines; 2014 Jan. (International Journal of Pharmaceutics; vol. 461, no. 1-2). |
| Peters JI. Cardiac constriction in a young male; 2014 Jan. |
| Levine SM, Singh H, Williams R, O`Donnell K., Lang B, Wang Y, Anzueto AR, Talbert R., Peters JI. Safety and Tolerability of Single Dose Inhaled Dry Powder Tacrolimus in Healthy Subjects; 2013 Oct. (Chest Meeting Abstracts). |
| Peters JI. Identification of CARDS toxin in the bronchial epithelial lining fluid after mycoplasma pneumoniae(Mp) inoculation: A primate Model; 2013 Oct. |
| Bayer, J, Das NA, Baisden CE, Rani M, Schwacha MG, Sako EY, Williams, RO, Peters JI, Johnson SB. Effect of inhaled tacrolimus on ischemia reperfusion injury in rat lung transplant model: Minneapolis, MN; 2013 May. (The Journal of Thoracic and Cardiovascular Surgery; vol. 146, no. 5). |
| Watts, AB, Wang, Y, Carvalho, S, Peters JI, Williams, RO. A Comprehensive DPI Platform for Delivery of Small Molecules and Biologics; 2013 Jan. (American Thoracic International Conference Abstracts; vol. 276, no. A4114). |
| Alan B. Watts, Yi-Bo Wang, Levine SM, Peters JI, Robert O. Williams. Development of Inhaled Tacrolimus: Human Safety and Formulation Improvements; 2012 May. (Respiratory Drug Delivery 2012; vol. 3). |
| Le Saux CJ, P. Schivshankar, Payan H, R.O. Williams, J., Peters JI. Inhaled Tacrolimus Protects Mice From Bleomycin-Induced Lung Fibrosis; 2012 May. (American Journal Respiratory and Critical Care Medicine). |
| Peters JI. Immunological Response to Mycoplasma pneumoniae and CARDS Toxin is related to severe histological inflammation and a TH2 response in a primate model; 2012 Jan. |
| Peters JI. Impact of Omalizumab in Severe Asthmatics With Marked Elevation of IgE; 2011 Oct. (Chest; vol. 140, no. 4). |
| Susanto IS, Sako EY, Anzueto AR, Levine SM, Peters JI, Cronin T, Jenkinson SG, Bryan C. Outcome of single lung transplants from the same donor: "Pulmonary Twinning"; 1995 Oct. (Chest; vol. 108, no. 3). |
Book Chapter |
| Shelledy DC, Peters JI. Introduction to Patient Assessment (Chapter 1). In: Shelledy DC, Peters JI. Respiratory Care: Patient Assessment and Care Plan Development. Burlington, Mass: Jones And Bartlett; 2014. p. 1-22. |
| Arora Anisha, Diaz Karla, Peters JI, Malave AJ. Bronchoscopy and other Diagnostic Studies(Chapter 13). In: Shelledy DC, Peters JI. Respiratory Care: Patient Assessment and Care Plan Development. Burlington, Mass: Jones and Bartlett; 2014. p. 543-555. |
| Vasquez Laura P., Shelledy DC, Peters JI. Cardiopulmonary Imaging (Chapter 11). In: Shelledy DC, Peters JI. Respiratory Care: Patient Assessment and Care Plan Development. Burlington, Mass: Jones and Bartlett; 2014. p. 428-498. |
| Shelledy DC, Peters JI. Patient History (Chapter 4). In: Shelledy DC, Peters JI. Respiratory Care: Patient Assessment and Care Plan Development. Burlington, Mass: Jones and Bartlett; 2014. p. 87-136. |
| Shelledy DC, Peters JI. Development and Implementation of Respiratory Care Plans (Chapter 2). In: Shelledy DC, Peters JI. Respiratory Care: Patient Assessment and Care Plan Development. Burlington, Mass: Jones And Bartlett; 2014. p. 23-58. |
| Burguete SR, DeArmond DT, Peters JI. Pneumothorax (in press). In: Fishman AP, Elias JA, Fishman JA, Grippi MA, Kaiser LR, Senior RM. Fishman's Pulmonary Diseases and Disorders, 5th edition (in press). NY: McGraw Hill; 2013. |
| Peters JI, Levine SM. Introduction to Pulmonary Function Testing, Chapter 32 (In press). In: Edited by J.T. DiPiro, R. L. Tabert, G.C Yee, G.R. Matzke, B.G Wells, L.M. Posey. Pharmacotherapy: A Pathophysiologic Approach. 2013. |
| Maselli DJ, Peters JI, Adams SG. Chapter 26: Hemoptysis. In: Editors: James F Shanahan and Robert Pancotti. The Patient History: An evidence-Based Approach to Differential Diagnosis. New York City, NY: McGraw-Hill Companies Inc; 2012. p. 251-257. |
Book/Monograph |
| Peters JI, Shelledy, David, Editor and co- authored for four chapters. Textbook of Respiratory Care Burlington,Mass: Jones and Bartlet Learning; 2014. |
Editorial |
| Maselli DJ, Peters JI. Five days of prednisone was noninferior to 14 days in patients with acute COPD exacerbation Ann Intern Med 2013 Sep;159(6):5-5. |
| Adams SG, Peters JI. Amoxicillin/clavulanate vs placebo: more exacerbation cures, fewer recurrences in mild-to-moderate COPD Annals of Internal Medicine ACP Journal Club 2013 Mar;158(6):3-3. |
Electronic/Web Publication |
| Peters JI. Macrolides for Severe Asthma 2017 Jul. |
| Peters JI. Smoking and Tobacco Use 2017 Jan. Available from: https://foundation.chestnet.org/patient-education-resources/smoking/ . |
| Peters JI. COPD: American Lung Association/American College of Chest Physicians 2016 Jun. |
| Peters JI. Pulmonary Arterial Hypertension: American Lung Association/American College of Chest Physicians 2016 Jun. |
| Peters JI. Asthma: American Lung Association/American College of Chest Physicians 2016 May. |
| Peters JI. Sarcoidosis: American Lung Association/American College of Chest Physicians 2016 May. |
| Peters JI. Case Studies in COPD: Therapy and Prevention of Exacerbations, Self Study Educational Module 2013 Sep. |
Journal Article |
| Fernandez-Restrepo L, Shaffer L, Amalakuhan B, Restrepo MI, Peters JI, Restrepo RD. Effects of intrapulmonary percussive ventilation on airway mucus clearance: a bench model World Journal of Critical Care Medicine 2017 Oct;. |
| Pamela Wood, MD; Jordan C Kampschmidt, BS; Peter H Dube, PhD; Marianna P Cagle, MA; Paola Chaparro, MS; Norma Ketchum; Thirumalai R Kannan, PhD; Harjinder Singh, MD; Jay I Peters, MD; Joel B Baseman, PhD; Edward G Brooks, MD. Mycoplasma pneumoniae and health outcomes in children with asthma Annals of Allergy, Asthma & Immunology 2017 Aug;. |
| Peters JI. Oral Glucocorticoid-sparing effect of benralizumab in severe asthma American College Physician Journal Club 2017 Jul;. |
| Mangat M, Amalakuhan B, Habib, Sheila, Reyes, LF, Hinojosa CA, Rodriguez AH, Soni NJ, Anzueto AR, Levine SM, Peters JI, Aliberti S, Sibila O, Rello J, Witzenrath M, Waterer G, Martin Loceches, Blanquer J, Sanz F, Marcos PJ, Sole-Violan, Chalmers JD, Feldman C, Wunderink RG, Cruz CSD, Orijuela CJ, Restrepo MI. High Endocan levels are associated with the need for mechanical ventilation among patients with severe sepsis European Respiratory Journal 2017 Jul;50(1). |
| Peters JI. Attenuation of lung and tumor fibrosis by fibroblast-specific inhibition of TGFB1 signaling Journal of Clinical Investigation 2017 Jan;. |
| Julien Maincent, Laura K. Najvar, William R. Kirkpatrick, Siyuan Huang, Thomas F. Patterson, Nathan P. Wiederhold, Peters JI, Robert O. Williams III. Modified Release Itraconazole Amorphous Solid Dispersion to Treat Aspergillus fumigatus: Importance of the Animal Model Selection. (In Press) Drug Development and Industrial Pharmacy 2016 Sep;. |
| Soto-Gomez N, Peters JI, Nambiar AM. Diagnosis and Management of Sarcoidosis Am Fam Physician 2016 May;93(10):840-848. |
| Maselli DJ, Peters JI. ACP Journal Club. Review: In COPD, tiotropium improves lung function and reduces adverse events compared with ipratropium bromide Annals of Internal Medicine 2016 Jan;164(2):6-6. |
| Hsu CH, Reyes LF, Orihuela CJ, Buitrago R, Anzueto A, Soni NJ, Levine S, Peters JI, Hinojosa CA, Aliberti S, Sibila O, Rodriguez A, Chalmers JD, Martin-Loeches I, Bordon J, Blanquer J, Sanz F, Marcos PJ, Rello J, Sole-Violan J, Restrepo MI. Chromogranin A levels and mortality in patients with severe sepsis Biomarkers 2015 Jul;20(3):171-176. |
| Maselli DJ, Peters JI. Review: Adding tiotropium to ICSs alone or with LABAs improves pulmonary function in asthma Annals of Internal Medicine 2015 Jun;162(12):5-5. |
| Shivshankar P, Payan H, Calhoun C, Levine SM, William R, Jagirdar J, Peters JI, Le Saux CJ. Inhaled Tacrolimus Modulates Pulmonary Fibrosis without Promoting Inflammation in Bleomycin-Injured Mouse Lungs Journal of Drug Delivery Science and Technology 2014 Sep;24(5):469-477. |
| Wiener RS, Ouellette DR, Diamond E, Fan VS, Maurer JR, Mularski RA, Peters JI, Halpern SD. An official American Thoracic Society/American College of Chest Physicians policy statement: the Choosing Wisely top five list in adult pulmonary medicine Chest 2014 Jun;145(6):1383-1391. |
| Wang YB, Watts AB, Peters JI, Liu S, Batra A, Williams RO. In Vitro and In Vivo Performance of Dry Powder Inhalation Formulations: Comparison of Particles Prepared by thin Film Freezing and Micronization. Epub AAPS PharmSciTech 2014 May;. |
| Renda Soylemez Wiener, Ouellette DR, Edward Diamond, Vincent S. Fan, Janet R. Maurer, Richard A. Mularski, Peters JI, Scott D. Halpern. The Choosing Wisely Top Five List in Adult Pulmonary Medicine Chest 2014 Jan;. |
| Hung JY, Horn, Diane, Woodruff, Kathleen, Prihoda, Thomas, LeSaux, Claude, Peters JI, Tio FO, Werner SL. Colony Stimulating Factor 1 Potentiates Lung Cancer Bone Metastasis Laboratory Investigation 2014 Jan;94(4):371-381. |
| Bayer J, Das NA, Basiden CE, Rani M, Schwacha MG, Sako EY, Williams RO, Peters JI, Johnson SB. Effect of inhaled tacrolimus on ischemia reperfusion injury in a rat lung transplant model The Journal of Thoracic and Cardiovascular Surgery 2013 Sep;146(5):1213-1219. |
| Maselli DJ, Peters JI. 5 days of prednisone was noninferior to 14 days in patients with acute COPD exacerbation Annals Internal Medicine 2013 Sep;159(6):5-5. |
| Purvis T, Pollack M, Coalson JJ, McNeish L, Williams III RO, Peters JI. Efficacy of Tacrolimus Nanoparticles Using In Vitro Cellular Assays for Immune Function.(submitted) Respiratory & Critical Care Medicine 2013 Aug;. |
| Burks ML, Brooks EG, Hill VL, Peters JI, Wood PR. Assessing proxy reports: agreement between children with asthma and their caregivers on quality of life Ann Allergy Asthma Immunol 2013 Jul;111(1):14-19. |
| Pamela R Wood, Vanessa L Hill, Margaret L Burks, BA; Jay I Peters, Harjinder Singh, Thirumalai R Kannan, Shruthi Vale, Marianna P Cagle, Molly F R Principe Joel B Baseman, Edward G Brooks,. Mycoplasma pneumoniae in children with acute and refractory asthma Ann Allergy Asthma Immunol 2013 May;110(5):328-334. |
| Maselli DJ, Adams SG, Peters JI, Levine SM. Management of asthma during pregnancy Therapeutic Advances in Respiratory Diseases 2013 Apr;7(2):87-100. |
| Jagirdar J, Chikkamuniyappa, S, Sirohi, D., McCarthy MJ, Peters JI. Cystic lung lesions in Sjogren syndrome: analysis of lymphocyte subsets in tissue with clinico-radiologic-pathologic correlation Ann Diagn Pathol 2013 Feb;17(1):113-116. |
| Jagirdar J, Chikkamuniyappa S, Sirohi D, McCarthy MJ, Peters JI. Cystic lung lesions in Sjogren syndrome: analysis of lymphocyte subsets in tissue with clinico-radiologic-pathologic correlation Ann Diagn Pathol. 2013; 17:113 2013 Feb;17(1):113-116. |
| Dugas HL, Peters JI, Robert O Williams III. Nebulization of Mycophenolate Mofetil Inhalation Suspension: Comparison with Oral and Pulmonary Administration of Cellcept? International Journal of Pharmaceutics 2013 Jan;441(1-2):19-29. |
| H. Dugas, Peters JI, R.O. Williams III. Pulmonary Bioavailability of an Inhaled Mycophenolate Mofetil Suspension: Comparison with the Nebulization of IV Cellcept Solution Proceedings of the American Association of Pharmaceutical Scientists 2012 Oct;. |
| Burguete SR, Levine SM, Restrepo MI, Angel LF, Levine DJ, Coalson JJ, Peters JI. Lung transplantation for Williams-Campbell syndrome with a probable familial association Respir Care 2012 Sep;57(9):1505-1508. |
| Peters JI, Stupka JE, Singh H, Rossrucker J, Angel LF, Melo J, Levine SM. Status asthmaticus in the medical intensive care unit: A 30-year experience Respir Med 2012 Mar;106(3):344-348. |
| H.L. Dugas, Peters JI, S.A. Stavchansky, R.O. Williams III. Hydrolysis of Mycophenolate Mofetil in Human Lung Epithelial Cells, Microsomes and Cyosol Fractions Biochemical Pharmacology (submitted) 2012 Jan;. |
| Peters JI, Stupka JE, Singh, Harjinder, Rossrucker, Jill, Angel L, Melo, Jairo, Levine SM. Status Asthmaticus in the Medical Intensive Care Unit: A Thirty Year Experience Respiratory Medicine 2012 Jan;106(3):344-348. |
| Burguete SR, Levine SM, Restrepo MI, Angel L, Levine DJ, Coalson JJ, Peters JI. A Role for Lung Transplantation in Williams-Campbell Syndrome Respiratory Care 2012 Jan;57(9):1505-1508. |
| Peters JI, Anzueto AR. Azithromycin once daily for 1 year reduced acute COPD exacerbations Annals of Internal Medicine ACP Journal Club 2012 Jan;156(2):1-10. |
| Peters JI, Singh, H., Brooks EG, Diaz, J., Kannan TR, Coalson JJ, Baseman, J, Cagle, M., Baseman JB. Persistence of Community-Acquired Respiratory Distress Syndrome Toxin-Producing Mycoplasma pneumoniae in Refractory Asthma Chest 2011 Aug;140(2):401-407. |
| Hardy, RD, Coalson JJ, Peters, JI, Chaparro, A, Techasaensiri, C, Cantwell AM, Kannan TR, Baseman JB, Dube PH. Analysis of Pulmonary Inflammation and Function in the Mouse and Baboon after Exposure to Mycoplasma pneumoniae CARDS Toxin Public Library of Science (PLoS ONE) 2009 Oct;4(10). |
Not Specified |
| Peters JI. Modified release itraconazole amorphous solid dispersion to treat Aspergillus fumigatus: importance of the animal model selection Industrial Pharmacy 2017 Feb;. |
| Peters JI. Iatrogenic Endobronchial bleeding: speed things up or cool it down? Interventional Pulmonology 2015 Jul;. |
| Peters JI. Adding tiotropium to ICSs alone or with LABAS improves pulmonary function in asthma Annals of Internal Medicine 2015 Jun;. |
| Peters JI. Characterization and pharmacokinetic analysis of crystalline versus amorphous rapamycin dry powser via pulmonary administration in rats Biopharmaceutics 2014 Sep;. |
| Peters JI. In vitro and in vivo performance of dry powder inhalation formulations:comparison of particles prepared by thin film freezing and micronization AAPS PharmSciTech 2014 Aug;. |
| Peters JI. Effect of inhaled tacrolimus on ishemia reperfusion injury in rat lung transplant model Cardiovascular surgery 2013 Nov;. |
| Peters JI. Assessing proxy reports: agreement between children with asthma and their caregivers on quality of life Annals of Allergy, Asthma 2013 Oct;. |
| Peters JI. Efficacy of omalizumab in asthmatic patients with IgE levels above 700 IU/mL : a retrospective study Annals of allergy, Asthma and Innumology 2013 Jun;. |
| Adams SG, Peters JI. ACP Journal Club. Amoxicillin/clavulanate vs placebo: more exacerbation cures, fewer recurrences in mild-to-moderate COPD Ann Intern Med 2013 Mar;158(6):3-3. |
| Peters JI. Nebulization of mycophenolate mofetil inhalation suspensionin rats: comparison with oral and pulmonary administration of cellcept International Journal of Pharmaceutics 2013 Jan;. |
Review Article |
| Yi-Bo Wang, Alan B. Watts, Peters JI, Robert O. Williams III. The Impact of Pulmonary Diseases on the Fate of Inhaled Medicines International Journal of Pharmaceutics 2014 Jan;461(1-2):112-128. |
| Maselli DJ, Adams S, Peters JI. The role of anti-infectives in the treatment of refractory asthma Ther Adv Respir Dis 2011 Dec;5(6):387-396. |
Federal |
|
| Funding Agency | NIH |
| Title | Genetic Epidemiology of Chronic Obstructive Pulmonary Disease |
| Status | Active |
| Period | 9/2007 - Present |
| Role | Co-Investigator |
| Grant Detail | Genetic Epidemiology of Chronic Obstructive Pulmonary Disease. The original local grant was approximately $1.2 million. Renewal Pending- 7/1/2012-06/30/2017 |
Private |
|
| Funding Agency | Merrell-Dow |
| Title | Use of Deflazocort in Chronic Asthma |
| Status | Active |
| Period | 10/1990 - Present |
| Role | Principal Investigator |
| Grant Detail | |